Netramark Holdings Inc. (formerly Nurosene Health Inc.)
|
|||
| Mailing Address: | Suite 101 - 1655 Dupont Street Toronto, ON M6P 3T1 |
Head Office Address: | Suite 101, 1655 Dupont Street Toronto, ON M6P 3T1 |
| Contact Name: | Swapan Kakumanu | Principal Regulator: | Ontario |
| Business e-mail address: | swapan@netramark.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 403 681-2549 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Ontario, Yukon |
| Fax Number: | Stock Exchange: | Canada - CSE | |
| Date of Formation: | May 8 2019 | Stock Symbol: | AIAI |
| Jurisdiction Where Formed: | BC | Auditor: | MNP LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | 64119M | Transfer Agent: | Odyssey Trust Company |
| Financial Year-End: | Sep 30 | Size of Issuer (Assets): | Under $5,000,000 |
|
